$92.93
+0.28 (+0.30%)
SAIC News4 articles
Leadership Shuffle at Pro Medicus Amid Valuation Debate
Pro Medicus announces new CFO amid a steep year-to-date stock decline, with analysts split on its valuation. Meanwhile, U.S. markets extend weekly losses on Middle East tensions.
Cellectar Biosciences Secures $140M, Pushes Iopofosine Toward FDA Filing
Cellectar Biosciences secured up to $140 million in new funding and reported strong Phase 2b results for iopofosine, fueling plans for a confirmatory trial and FDA filing in Waldenström macroglobulinemia.
Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial
Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.
Firefly Neuroscience Soars 126% on AI Brain-Scan Surge and Nvidia Partnership
Firefly Neuroscience shares surged 126% following a massive expansion in its commercial brain-scan platform and a new AI initiative powered by NVIDIA hardware. The company reported a 33-fold increase in scan volumes to over 10,800 in 2025.